Back to Authors

Knight, Andrew Michael

0000-0002-7934-4150

Mayo Clinic

Mayo Clinic

Citations 6

A safety study on intrathecal delivery of autologous mesenchymal stromal cells in rabbits directly supporting Phase I human trials
Chen, Bingkun K. , Staff, Nathan P. , Nesbitt, Jarred J., Butler, Greg W., Padley, Douglas, Parisi, Joseph E. , Dietz, Allan B. , Windebank, Anthony J. , Knight, Andrew M, Padley, Douglas J, Knight, Andrew Michael , Staff, Nathan P , Dietz, Allan B

Transfusion | November 21, 2014 | Volume: 55 | Issue: 5 | Pages: 1013-1020

10.1111/trf.12938 Get It

BackgroundThere are no effective treatments that slow the progression of neurodegenerative diseases. A major challenge of treatment in neurodegenerative diseases is appropriate delivery of pharmaceuticals into the cerebrospinal fluid (CSF) of affected individuals. Mesenchymal stromal cells (MSCs—either naïve or modified) are a promising therapy in neurodegenerative diseases and may be delivered directly into the CSF where they can reside for months. In this preclinical study, we evaluated the safety of intrathecal autologous MSCs in a rabbit model.Study Design and MethodsAutologous adipose‐derived MSCs (or artificial CSF) were delivered intrathecally, either with single or with repeated injections into the foramen magnum of healthy rabbits and monitored for 4 and 12 weeks, respectively.ResultsRabbits tolerated injections well and no definitive MSC‐related side effects were observed apart from three rabbits that had delayed death secondary to traumatic foramen magnum puncture. Functional assessments and body weights were equivalent between groups. Gross pathology and histology did not reveal any abnormalities or tumor growth. Complete blood count data were normal and there were no differences in CSF interleukin‐6 levels in all groups tested.ConclusionOur data suggest that intrathecal delivery of autologous MSCs is safe in a rabbit model. Data from this study have supported two successful investigational new drug applications to the Food and Drug Administration, resulting in the initiation of two clinical trials using autologous MSCs in amyotrophic lateral sclerosis and multiple system atrophy.
Comparison of Cellular Architecture, Axonal Growth, and Blood Vessel Formation Through Cell-Loaded Polymer Scaffolds in the Transected Rat Spinal Cord
Madigan, Nicolas N. , Chen, Bingkun K. , Rooney, Gemma E., Sweeney, Eva , Kinnavane, Lisa , Yaszemski, Michael J. , Dockery, Peter , McMahon, Siobhán S. , Windebank, Anthony J. , Knight, Andrew Michael , O’Brien, Timothy

Tissue Engineering Part A | May 22, 2014 | Volume: 20 | Issue: 21-22 | Pages: 2985-2997

10.1089/ten.tea.2013.0551 Get It

Sustained Delivery of Dibutyryl Cyclic Adenosine Monophosphate to the Transected Spinal Cord Via Oligo [(Polyethylene Glycol) Fumarate] Hydrogels
Rooney, Gemma E., Madigan, Nicolas N. , Gross, LouAnn, Chen, BingKun, Vallejo‐Giraldo, Catalina , Seo, Seungmae , Nesbitt, Jarred J., Dadsetan, Mahrokh, Yaszemski, Michael J. , Windebank, Anthony J. , Knight, Andrew Michael

Tissue Engineering Part A | January 4, 2011 | Volume: 17 | Issue: 9-10 | Pages: 1287-1302

10.1089/ten.tea.2010.0396 Get It

Axon Regeneration through Scaffold into Distal Spinal Cord after Transection
Chen, Bing Kun, Ruiter, Godard C. W. de , Spinner, Robert J. , Yaszemski, Michael J. , Currier, Bradford L. , Windebank, Anthony J. , Knight, Andrew Michael

Journal of Neurotrauma | June 23, 2009 | Volume: 26 | Issue: 10 | Pages: 1759-1771

10.1089/neu.2008.0610 Get It

Neural Stem Cell– and Schwann Cell–Loaded Biodegradable Polymer Scaffolds Support Axonal Regeneration in the Transected Spinal Cord
Olson, Heather E. , Rooney, Gemma E., Gross, LouAnn, Nesbitt, Jarred J., Galvin, Katherine E., Chen, BingKun, Yaszemski, Michael J. , Windebank, Anthony J. , Knight, Andrew Michael

Tissue Engineering Part A | February 3, 2009 | Volume: 15 | Issue: 7 | Pages: 1797-1805

10.1089/ten.tea.2008.0364 Get It

Charged Modification of Hydrogel for Nerve Regeneration
Dadsetan, Mahrokh, Vallejo‐Giraldo, Catalina , Lu, Lichun , Windebank, Anthony J. , Yaszemski, Michael J. , Knight, Andrew Michael

Journal of Medical Devices | July 10, 2008 | Volume: 2 | Issue: 2 | Pages: No page available

10.1115/1.2934347 Get It

Natural and synthetic hydrogels have attracted much attention for nerve regeneration. Previous studies have shown that electrical charge has significant effect on stimulation of neurite outgrowth. In this work, incorporation of a positively charged monomer into the photocrosslinkable oligo(polyethylene glycol) fumarate (OPF) hydrogel has been investigated. We have evaluated the effect of localized positive charge on neurite outgrowth in culture with an objective that positively charged hydrogels ultimately can be used for stimulating in vivo nerve regeneration. The effect of charged modification has been also studied on mechanical properties and swelling ratio of these hydrogels. Our data indicated that with increasing charge density hydrogels swelling ratio increased in water, however it remained constant in PBS. We also demonstrated that compressive modulus and tensile strength of the hydrogels improved with incorporation of electrical charge into the hydrogels. Biodegradation of modified hydrogels was investigated in a series of biomimetic solutions. OPF hydrogels appeared to be more susceptible to oxidative degradation as opposed to the hydrolytic degradation in enzymes and acidic solution, and the degradation rate was correlated to the PEG molecular weight and charge density of the hydrogels. To investigate the effect of charge modification on nerve cell attachment and differentiation, dissociated dorsal root ganglion (DRG) cells were plated onto the modified and unmodified hydrogels surfaces. DRG cells attached and extended their neurites more readily on the surface of positively charged hydrogels as opposed to the unmodified hydrogels.